cabozantinib
exelixis
['improve', 'atlantis', 'cabozantinib', 'muc ,(-much)']
dr. robert jones presented results of atlantis trial evaluating the benefit of maintenance cabozantinib in muc patients (cr, ps and sd) (similar to javelin). cabo failed to improve mpfs. #asco22 
Medical oncologist at @BPorgbr. Former fellow of GU oncology @DanaFarber @Harvard @MOCbrasil. #GUcancer